Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
1302 On Other Exchanges
1302 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

lifetech scientific corp (1302) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LIFETECH SCIENTIFIC CORP (1302)

Related News

No related news articles were found.

lifetech scientific corp (1302) Related Businessweek News

No Related Businessweek News Found

lifetech scientific corp (1302) Details

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide. The company operates through Congenital Heart Diseases, Peripheral Vascular Diseases, and Surgical Vascular Repair segments. Its products include HeartR, Cera, and CeraFlex congenital heart defect occluders; delivery systems, such as FuStar steerable introducers and SteerEase introducers; balloon catheters comprising Green Arrow PBAV balloon catheters, Blue Arrow PBMV balloon catheter sets, Red Arrow PBPV balloon catheter sets, and AcuMark sizing balloons; Cera vascular plug systems; Aegisy vena cava filters; Ankura stent graft systems; SeQure snare systems; and associated delivery and supporting devices. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the People’s Republic of China.

583 Employees
Last Reported Date: 04/2/15
Founded in 1999

lifetech scientific corp (1302) Top Compensated Officers

Chairman, Chief Executive Officer, Member of ...
Total Annual Compensation: CNY520.0K
Compensation as of Fiscal Year 2013.

lifetech scientific corp (1302) Key Developments

LifeTech Scientific Corporation Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2014

LifeTech Scientific Corporation announced audited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported revenue of RMB 282,679,000 against RMB 231,035,000 a year ago. Operating profit was RMB 49,784,000 against RMB 42,205,000 a year ago. Loss before tax was RMB 67,811,000 against RMB 53,193,000 a year ago. Loss for the year attributable to owners of the company was RMB 81,244,000 or RMB 0.020 basic and diluted per share against RMB 65,666,000 or RMB 0.016 basic and diluted per share a year ago. Net cash from operating activities was RMB 19,527,000 against RMB 34,963,000 a year ago. Deposits paid for and purchase of property, plant and equipment were RMB 30,944,000 against RMB 14,273,000 a year ago. Payments for intangible assets were RMB 387,000 against RMB 116,000 a year ago. The growth in revenue was mainly attributable to the rapid increase of sales of stent graft by approximately RMB 20.7 million or approximately 39.8% and vena cava filter by approximately RMB 14.5 million or approximately 26.5%. The increase in operating profit was primarily due to the increase of sales revenue. The net loss was mainly attributable to the continuous record of the fair value loss of conversion option of the First Tranche Convertible Notes issued on January 30, 2013; and the increase in administration expenses.

Lifetech Scientific Corporation Announces Board Changes

The board of directors of LifeTech Scientific Corporation announced that Dr. LIDDICOAT John Randall has resigned as a non-executive director of the company with effect from 27 March 2015 due to his intention to devote more time to his other business and personal engagements. The board also announced that Mr. MONAGHAN Shawn Del has been appointed as a non-executive Director with effect from 27 March 2015. Mr. MONAGHAN currently serves as the Vice President of Business Development and Strategy for Cardiac Rhythm and Heart Failure (CRHF) business of Medtronic Inc. The Board further announced that Mr. LIU Jianxiong has been re-designated from a non-executive Director to an executive Director with effect from 27 March 2015, after taking into consideration of the structure, size and diversity of the Board, and the role and responsibility of Mr. LIU within the company, who is also the chief financial officer and company secretary of the group.

Lifetech Scientific Corporation Provides Earnings Guidance for the Full Year Ended December 31, 2014

Lifetech Scientific Corporation provided earnings guidance for the full year ended December 31, 2014. For the year ended December 31, 2014, the expected fair value loss will be approximately RMB 116,443,000, which represents an increase of approximately 74.4% as compared to the fair value loss incurred during the year in 2013. The increase of the fair value loss was caused by the increase on share price of the company in the year ended December 31, 2014. Based on the expectation that there will be an increase in operating profit for the year ended December 31, 2014 as compared to the year of 2013 before taking into account the fair value loss which is non-operating and non-cash in nature, the board is of the view that the Group's operating and financial positions are healthy and the board remains positive on the prospects of the Group.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1302:HK $1.40 HKD -0.01

1302 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1302.
View Industry Companies

Industry Analysis


Industry Average

Valuation 1302 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 15.9x
Price/Book 29.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIFETECH SCIENTIFIC CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at